Shalom Wealth

If clinical trials were the engines of innovation, artificial intelligence (AI) is becoming their turbocharger. Across the research lifecycle—from trial design to recruitment and analysis—AI is accelerating processes that once took years.

In clinical research, diversity isn’t just a buzzword—it’s biological necessity. Drugs that treat common conditions like hypertension or diabetes may metabolize differently depending on genetic factors, ethnicity, and socioeconomic conditions.

Clinical research is undergoing a seismic shift. No longer confined to academic hospitals and urban research centers, clinical trials are now entering patients’ homes, enabled by digital technology and telemedicine.